Return to search

Thyroid Dysfunction with Targeted Chemotherapy Agents

1. Evaluate the mechanisms by which hyperglycemia and hypothyroidism occur in patients on certain targeted chemotherapy agents.2. Develop treatment recommendations for patients who develop these endocrine toxicities while on therapy.3. Establish appropriate monitoring guidelines for patient receiving certain targeted chemotherapy agents.

Identiferoai:union.ndltd.org:ETSU/oai:dc.etsu.edu:etsu-works-3455
Date22 October 2012
CreatorsBossaer, John B.
PublisherDigital Commons @ East Tennessee State University
Source SetsEast Tennessee State University
Detected LanguageEnglish
Typetext
SourceETSU Faculty Works

Page generated in 0.0017 seconds